EE393 The Cost-Effectiveness of Atidarsagene Autotemcel (Arsa-Cel) for the Treatment of Metachromatic Leukodystrophy (MLD) in the US.

Saved in:
Bibliographic Details
Title: EE393 The Cost-Effectiveness of Atidarsagene Autotemcel (Arsa-Cel) for the Treatment of Metachromatic Leukodystrophy (MLD) in the US.
Authors: Pang, F.1 (AUTHOR), Dean, R.2 (AUTHOR), Jensen, I.S.2 (AUTHOR), Bean, K.1 (AUTHOR), Fields, C.3 (AUTHOR), Miller, B.2 (AUTHOR)
Source: Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS126-S126. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2023.09.659